Seattle, WA, United States of America

Elizabeth Dam

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Deverra Therapeutics Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth Dam. Retrieved from https://idiyas.com/inventor/elizabeth-dam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elizabeth Dam: Innovator in Immunotherapy

Introduction

Elizabeth Dam is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of immunotherapy, particularly through her innovative research and development efforts.

Latest Patents

Elizabeth holds a patent for "NK Cell Compositions and Preparations for Immunotherapy and Methods for Their Production." This patent highlights her work in creating effective treatments that harness the power of natural killer cells to combat diseases.

Career Highlights

Elizabeth is currently associated with Deverra Therapeutics Inc., where she continues to advance her research in immunotherapy. Her dedication to innovation has positioned her as a key figure in her field.

Collaborations

Throughout her career, Elizabeth has collaborated with notable colleagues, including Colleen Delaney and Carrie Stoltzman. These partnerships have further enhanced her research and development efforts.

Conclusion

Elizabeth Dam is a trailblazer in the field of immunotherapy, with her patent and collaborative efforts contributing to advancements in medical science. Her work exemplifies the impact of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…